O99.820 Streptococcus B carrier state complicating pregnancy

Name of the Condition

• Streptococcus B carrier state complicating pregnancy
• ICD-10 Code: O99.820

Summary

This code represents a maternal carrier state of Group B Streptococcus (GBS) during pregnancy, childbirth, or the puerperium. The condition involves colonization with GBS bacteria without active infection but requires clinical attention due to potential risks to the fetus or newborn. Management focuses on preventing perinatal transmission, which can lead to serious neonatal complications.

Causes

The underlying cause is colonization with Group B Streptococcus bacteria, typically acquired through asymptomatic vaginal or rectal carriage. The bacteria may be present in the maternal genital tract without causing symptoms in the mother but can pose risks during delivery or postpartum. Pregnancy-related physiological changes do not cause the carrier state but may influence transmission risk.

Risk Factors

• Maternal GBS colonization (detected via screening)
• Preterm labor or preterm premature rupture of membranes (PPROM)
• Prolonged rupture of membranes (≥18 hours)
• Intrapartum fever or chorioamnionitis
• Previous infant with invasive GBS disease
• Maternal GBS bacteriuria during pregnancy

Symptoms

The maternal carrier state is typically asymptomatic. However, symptoms may arise if GBS progresses to infection, such as:

• Maternal fever or chills (if bacteremia occurs)
• Fetal distress or preterm labor (if chorioamnionitis develops)
• Neonatal symptoms (e.g., respiratory distress, sepsis) if transmission occurs

Diagnosis

Diagnosis involves screening for GBS colonization, usually performed between 36–37 weeks of gestation via vaginal and rectal swabs. Cultures are the standard method, with results indicating carrier status. Intrapartum diagnosis may include rapid PCR testing if cultures are unavailable. Neonatal testing (e.g., blood cultures) is done if signs of infection appear after birth.

Treatment Options

• Intrapartum antibiotic prophylaxis (e.g., penicillin or ampicillin) for GBS-positive mothers to reduce transmission risk
• Close monitoring of the newborn for signs of infection (e.g., temperature instability, respiratory distress)
• Postpartum care for the mother, including monitoring for maternal infection if symptoms develop

Prognosis and Follow-Up

With appropriate intrapartum prophylaxis, the risk of neonatal GBS disease is significantly reduced. Most carriers have uncomplicated pregnancies and deliveries. Follow-up involves monitoring the newborn for 24–48 hours post-birth and ensuring maternal recovery. Long-term prognosis is favorable if no transmission occurs.

Complications

• Neonatal sepsis, pneumonia, or meningitis if GBS is transmitted
• Maternal postpartum infection (e.g., endometritis) if untreated
• Preterm birth or stillbirth in rare cases

Lifestyle & Prevention

• Routine prenatal screening for GBS at 36–37 weeks
• Prompt treatment with antibiotics during labor for GBS-positive mothers
• Good hygiene practices during pregnancy (e.g., handwashing)
• Avoiding unnecessary invasive procedures that may increase infection risk

When to Seek Professional Help

• If signs of maternal infection appear (e.g., fever, chills, uterine tenderness)
• If the newborn shows symptoms of infection (e.g., poor feeding, lethargy, respiratory distress)
• If preterm labor or PPROM occurs, as these increase transmission risk

Tips for Medical Coders

Document the presence of GBS colonization, screening results, and any intrapartum antibiotic prophylaxis. Ensure the code is applied when the carrier state complicates pregnancy, childbirth, or the puerperium. Include details of maternal screening, labor management, and neonatal outcomes if relevant to support clinical coding accuracy.